• Issue

    Journal of Thrombosis and Haemostasis: Volume 17, Issue 8

    1-1409
    August 2019
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information

  • Pages: 1-4
  • First Published: 31 July 2019

What the Neighbours Say

Free Access

What the Neighbours Say

  • Pages: 1199-1200
  • First Published: 31 July 2019

Neighborhood Watch

Free Access

Endothelial force awakens a mechanism of portal hypertension: It's a neutrophil extracellular trap!

Dafna J. Groeneveld,  James P. Luyendyk, 
  • Pages: 1201-1204
  • First Published: 28 June 2019

Review Articles

Free Access

Disseminated intravascular coagulation in cardiac arrest and resuscitation

Satoshi Gando,  Takeshi Wada, 
  • Pages: 1205-1216
  • First Published: 18 May 2019
Free Access

Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis

Cecilia Becattini,  Michela Giustozzi,  Pau Cerdà,  Ludovica A. Cimini,  Antoni Riera-Mestre,  Giancarlo Agnelli, 
  • Pages: 1217-1228
  • First Published: 07 May 2019
Open Access

Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding

Mark Schreuder,  Pieter H. Reitsma,  Mettine H. A. Bos, 
  • Pages: 1229-1239
  • First Published: 18 May 2019

Haemostasis

Free Access

Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding

Junjiang Sun,  Eric W. Livingston,  Mie L. Broberg,  Peter B. Johansen,  Carsten D. Ley,  Tom Knudsen,  Mirella Ezban,  Ted Bateman,  Paul E. Monahan,  Sarah Taves, 
  • Pages: 1240-1246
  • First Published: 31 May 2019

Recommendations and Guidelines

Free Access

Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH

Aurelien Delluc,  Tzu-Fei Wang,  Eng-Soo Yap,  Cihan Ay,  Jordan Schaefer,  Marc Carrier,  Simon Noble, 
  • Pages: 1247-1252
  • First Published: 18 May 2019
Open Access

Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH

Karyn Megy,  Kate Downes,  Ilenia Simeoni,  Loredana Bury,  Joannella Morales,  Rutendo Mapeta,  Daniel B. Bellissimo,  Paul F. Bray,  Anne C. Goodeve,  Paolo Gresele,  Michele Lambert,  Pieter Reitsma,  Willem H. Ouwehand,  Kathleen Freson, on behalf of the Subcommittee on Genomics in Thrombosis and Hemostasis , 
  • Pages: 1253-1260
  • First Published: 18 May 2019
Open Access

Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity

Rienk Nieuwland,  Chris Gardiner,  Françoise Dignat-George,  François Mullier,  Nigel Mackman,  Barry Woodhams,  Johannes Thaler, 
  • Pages: 1261-1264
  • First Published: 16 May 2019
Free Access

Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation

Toshiaki Iba,  Jerrold H. Levy,  Kazuma Yamakawa,  Jecko Thachil,  Theodore E. Warkentin,  Marcel Levi,  The Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis , 
  • Pages: 1265-1268
  • First Published: 16 May 2019

Commentary

Free Access

Emicizumab and thrombosis: The story so far

Michael Makris,  Alfonso Iorio,  Peter J. Lenting, 
  • Pages: 1269-1272
  • First Published: 31 July 2019

CLINICAL HAEMOSTASIS AND THROMBOSIS

Original Articles

Open Access

Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application

Jonathan Douxfils,  Laure Morimont,  Céline Bouvy,  Marie de Saint-Hubert,  Bérangère Devalet,  Célia Devroye,  Anne-Sophie Dincq,  Jean-Michel Dogné,  Maïté Guldenpfennig,  Justine Baudar,  Anne-Sophie Larock,  Sarah Lessire,  François Mullier, 
  • Pages: 1273-1287
  • First Published: 07 May 2019
Free Access

Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates

Barbara Lunghi,  Francesco Bernardi,  Nicola Martinelli,  Sabrina Frusconi,  Alessio Branchini,  Silvia Linari,  Giovanna Marchetti,  Giancarlo Castaman,  Massimo Morfini, 
  • Pages: 1288-1296
  • First Published: 04 May 2019
Open Access

Endogenous sex hormones and risk of venous thromboembolism in young women

Luuk J. J. Scheres,  Astrid van Hylckama Vlieg,  Bart E. P. B. Ballieux,  Bart C. J. M. Fauser,  Frits R. Rosendaal,  Saskia Middeldorp,  Suzanne C. Cannegieter, on behalf of the CREW consortium , 
  • Pages: 1297-1304
  • First Published: 04 May 2019
Free Access

Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population-based cohort study

Kasper Adelborg,  Priscila Corraini,  Bianka Darvalics,  Henrik Frederiksen,  Anne Ording,  Erzsébet Horváth-Puhó,  Mikael Rørth,  Henrik T. Sørensen, 
  • Pages: 1305-1318
  • First Published: 04 May 2019
Open Access

Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran

Stephan Glund,  Kelly Coble,  Dietmar Gansser,  Joachim Stangier,  Karin Hoermann,  Charles V. Pollack,  Paul Reilly, 
  • Pages: 1319-1328
  • First Published: 03 May 2019
Free Access

Could the YEARS algorithm be used to exclude pulmonary embolism during pregnancy? Data from the CT-PE-pregnancy study

Emilie Langlois,  Camille Cusson-Dufour,  Thomas Moumneh,  Antoine Elias,  Guy Meyer,  Karine Lacut,  Jeannot Schmidt,  Catherine Le Gall,  Céline Chauleur,  Frédéric Glauser,  Helia Robert-Ebadi,  Marc Righini,  Grégoire Le Gal, 
  • Pages: 1329-1334
  • First Published: 20 May 2019
Open Access

Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer

Ella Grilz,  Christine Marosi,  Oliver Königsbrügge,  Julia Riedl,  Florian Posch,  Wolfgang Lamm,  Irene M. Lang,  Ingrid Pabinger,  Cihan Ay, 
  • Pages: 1335-1344
  • First Published: 17 May 2019
Free Access

Monitoring of blood coagulation with non-contact drop oscillation rheometry

Vahideh Ansari Hosseinzadeh,  Carlo Brugnara,  Sirisha Emani,  Damir Khismatullin,  R. Glynn Holt, 
  • Pages: 1345-1353
  • First Published: 16 May 2019
Free Access

Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon

Glynis Frans,  Peter Meeus,  Els Bailleul, 
  • Pages: 1354-1362
  • First Published: 18 May 2019

VASCULAR BIOLOGY

Original Articles

Free Access

Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism

Birgit Småbrekke,  Ludvig B. Rinde,  Line H. Evensen,  Vania M. Morelli,  Kristian Hveem,  Maiken E. Gabrielsen,  Inger Njølstad,  Ellisiv B. Mathiesen,  Frits R. Rosendaal,  Sigrid K. Brækkan,  John-Bjarne Hansen, 
  • Pages: 1363-1371
  • First Published: 24 May 2019
Free Access

von Willebrand factor in experimental malaria-associated acute respiratory distress syndrome

Sirima Kraisin,  Sebastien Verhenne,  Thao-Thy Pham,  Kimberly Martinod,  Claudia Tersteeg,  Nele Vandeputte,  Hans Deckmyn,  Karen Vanhoorelbeke,  Philippe E. Van den Steen,  Simon F. De Meyer, 
  • Pages: 1372-1383
  • First Published: 17 May 2019
Free Access

The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen

Laura L. Swystun,  Kenichi Ogiwara,  Jesse D. Lai,  Juha R. M. Ojala,  Orla Rawley,  Fanny Lassalle,  Colleen Notley,  Olle Rengby,  Alison Michels,  Kate Nesbitt,  Karl Tryggvason,  David Lillicrap, 
  • Pages: 1384-1396
  • First Published: 24 May 2019

Letters to the Editor

Free Access

Thromboprophylaxis in pregnant women: For whom and which LMWH dosage? Reply

Claire McLintock,  Stephanie Cox,  Renee Eslick, 
  • Pages: 1397-1398
  • First Published: 31 July 2019
Free Access

Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

Rahat A. Abdoellakhan,  Jan Beyer-Westendorf,  Sam Schulman,  Ravi Sarode,  Karina Meijer,  Nakisa Khorsand, 
  • Pages: 1398-1399
  • First Published: 31 July 2019
Free Access

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

Jamal Rahmani,  Siamak Sabour, 
  • Page: 1400
  • First Published: 31 July 2019
Free Access

Thromboprophylaxis in pregnant women: For whom and which LMWH dosage?

Bernard Tardy,  Andrea Buchmuller,  Ingrid M. Bistervels,  Fionnuala Ni Ainle,  Saskia Middeldorp, 
  • Pages: 1401-1403
  • First Published: 31 July 2019
Free Access

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Comment

Wolfgang Miesbach, 
  • Pages: 1403-1405
  • First Published: 06 May 2019
Free Access

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply

Flora Peyvandi, 
  • Pages: 1405-1406
  • First Published: 31 July 2019

Announcements

Free Access

ISTH News and Updates: Join the ISTH Today

  • Pages: 1407-1409
  • First Published: 31 July 2019